On September 11–17, 2026, Ekaterinburg hosted the International Youth Festival, a large-scale event that brought together 10,000 young leaders from 191 countries. At the festival running under the motto «Follow Your Dream,» the Medsintez Plant presented its exhibition, showcasing the achievements of the Ural pharmaceutical industry in the field of import substitution.
The updated clinical guidelines for treatment of ARVI in children took effect on September 2, 2026. The document was developed by leading experts from the Union of Pediatricians of Russia, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and the Russian Society of Emergency Medical Care and approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation. It fundamentally shifts therapeutic approaches toward enhanced safety and minimal drug burden.
On September 3–4, 2026, Nizhny Novgorod hosted the 2nd Regional Endocrinological Congress: Challenges and Prospects of the Volga Region, with the active participation of the Medsintez Plant. As a strategic company, Medsintez Plant has been ensuring Russia's pharmaceutical security for 25 years. Company's exhibition booth showcased a range of hormonal medications for treatment of type 1 and type 2 diabetes, as well as drugs for infertility treatment through the IVF method.
More than twenty years ago, the Regiony Rossii (Regions of Russia, RR) magazine witnessed the birth of an innovative pharmaceutical production facility in Novouralsk, which had no analogues in the country. Today, the Medsintez Plant is a strategic asset in terms of national pharmaceutical security, a recognized industry leader, a National Champion, and a winner of prestigious awards. The secret behind the success of the Ural school of pharmaceuticals and biotechnology is explored in this article by RR.

The TRONITEK LLC company is engaged in the development and production of radio-electronic, medical and rehabilitation equipment. TRONITEK LLC has a high- tech production facilities, all manufactured products are subject to careful quality control. The main activity of the company is the development and production of high-tech medical products. The product range includes a whole line of universal and specialized devices for home and professional physiotherapy based on 2 technologies – dynamic electrical neurostimulation (DENS) and neuron-like dynamic electrical neurostimulation (NEURODENS).
DENS is a physiotherapy technique based on the impact on reflexogenous zones and acupuncture points with low- frequency short-pulse current for therapeutic and prophylactic purposes. Proven therapeutic effects: analgesic, anti-inflammatory, vascular, immunomodulatory, anti-stress.
NEURODENS is a medical technology based on the impact of weak pulse currents of a special sinusoidally damped shape, resembling a human nerve impulse, on biologically active zones and points in order to obtain specific therapeutic effects.
Specialized devices are designed for the treatment of acute and chronic pain in the joints, back, for the treatment of pain in the neck and shoulder girdle, for the correction of blood pressure, the correction of age-related changes in the skin of the face, etc.
Universal devices are used for the prevention and treatment of a wide range of diseases both at home and in health care institutions. Remote electrodes are used to increase the effectiveness of the impact on individual zones, reduce the complexity of self- care procedures.
The DENS and NEURODENS techniques have no age restrictions, and they are indicated to use on adults and children. For this technique, 40 doctoral and candidate works have been defended, more than 1000 scientific articles have been written, including 5 monographs and more than 20 recommended practices for medical practitioners. All this guarantees the high quality and efficiency of the manufactured devices.
5, Soboleva St, Ekaterinburg, 620036
Tel.: 8-800-250-20-42
E-mail: sale@tronitek.ru
www.tronitek.ru; www.neurodens.ru







